Antios Therapeutics picks up $96m Series B

Antios Therapeutics Inc, a clinical-stage biopharmaceutical company focused on treating viral diseases, has raised $96 million in Series B financing.

Antios Therapeutics Inc, a clinical-stage biopharmaceutical company focused on treating viral diseases, has raised $96 million in Series B financing. Soleus Capital led the round.

Source: Press Release